Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by AlwaysL8on Mar 17, 2017 8:05am
103 Views
Post# 25992217

RE:ADK First Mover Bring The News !

RE:ADK First Mover Bring The News !That was a decent article, thanks for posting Bob.
The more I think about it the more I agree with this move. Diversification, little bit of income, no expense, all good.

I really think things are going to change around here shortly. The Mexico contract has to come to a head sooner than later. Follow up with analyst coverage starting in April. I imagine we should see multiple NR coming out of Saudi late April as well. US market I have no idea what to expect. Really there are two reasonable opportunities at this point, one coming out of Flordia, the other California. Both could be game changers, but I'm really not sure how we are positioned, are we still trying to make in roads or are we a little past that?
As we move towards transforming pilots into contracts I see big pharma playing a smaller role, and I do not anticipate seeing any sort of aqusition offer. 
Should continue to be another slow day, hope you guys are taking advantage of the MM games.

Bullboard Posts